The Patent Finder

Terms ending in 2027

ZymoGenetics Inc.

Every in-force patent on ZymoGenetics Inc.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 7,514,077Methods of Antagonizing Signal Transduction in Dorsal Root Ganglion Cells with IL-31 Antagonists
In force
 · High confidence
ZymoGenetics, Inc.In forceHigh confidence
US 7,638,126Methods of Treating Pain and Inflammation in Neuronal Tissue Using Antagonists of IL-31, IL-31RA And/Or Osmrb
In force
 · High confidence
ZymoGenetics, Inc.In forceHigh confidence
US 8,637,015Methods of Antagonizing Signal Transduction in Dorsal Root Ganglion Cells
In force
 · Low confidence
ZymoGenetics, Inc.In forceLow confidence
US 8,685,395Methods of Antagonizing Signal Transduction in Dorsal Root Ganglion Cells
In force
 · Low confidence
ZymoGenetics, Inc.In forceLow confidence
US 8,968,732Methods of Treating Pain Using an IL-31 Monoclonal Antibody
In force
 · Medium confidence
ZymoGenetics, Inc.In forceMedium confidence
US 8,974,783Methods of Treating Pain Using an IL-31RA or Osmr-B Antagonist
In force
 · Low confidence
ZymoGenetics, Inc.In forceLow confidence
US 9,334,321Methods of Treating Neuronal Inflammation Using an IL-31 Monoclonal Antibody
In force
 · Low confidence
ZymoGenetics, Inc.In forceLow confidence
US 9,334,322Methods of Antagonizing Signal Transduction in Spinal Cord Cells Using an IL-31RA or Osmr-B Antagonist
In force
 · Medium confidence
ZymoGenetics, Inc.In forceMedium confidence
US 9,631,021Use of an IL-31 Monoclonal Antibody for Antagonizing Signal Transduction in Spinal Cord Cells
In force
 · Medium confidence
ZymoGenetics, Inc.In forceMedium confidence
US 9,631,022Method Treating Neuronal Tissue Inflammation Using an IL-31RA Monoclonal Antibody
In force
 · Low confidence
ZymoGenetics, Inc.In forceLow confidence
16 more term ends in 2027 · Pro
10 of 26 patents shown. Soonest term end first, then patent number.
Pro members see all 26, all of them expiring within the 18 months from Nov 18, 2026.
Upgrade to Pro
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited